GSK logo

US Medical Affairs Lead, Neisseria

GSK
Remote friendly (Philadelphia, PA)
United States
$217,500 - $362,500 USD yearly
Medical Affairs

Role Summary

US Medical Affairs Lead for the Neisseria portfolio. You will lead the development and execution of the US medical affairs strategy, supporting growth and aligning cross-functional partners. The role reports to the Head, Pediatric, Adolescent & Pipeline Vaccines Portfolio. Location: Philadelphia, PA; Waltham, MA; Upper Providence, PA, USA.

Responsibilities

  • Accountable for overall medical strategy, development of the medical plan, and achievement of tactical objectives for the Neisseria portfolio.
  • Ensure strategic alignment and collaboration with Commercial, Global Medical, and cross-functional partners to understand the US landscape, market value drivers, unmet needs, and communicate timelines for success.
  • Represent US medical in cross-functional strategy meetings and workshops, proposing options for medical strategy and innovative activities.
  • As a core member of the Global Medical Team, jointly develop the global medical strategy and integrate the US medical environment and voice of the customer.
  • Accountable for the Global Integrated Medical Communication Plan (IMCP) and scientific narrative; support data gaps identification and data-generation strategy including US data needs; provide US input at key inflection points during development.
  • Serve as internal expert on the Neisseria portfolio, maintaining deep product, disease, and landscape expertise; ensure US insights are integrated into cross-functional strategy (IBCT).
  • Lead/contribute to US scientific engagement with external communities to advance understanding of vaccines, disease management, and patient care; coordinate with Medical Directors and Field Medical as needed.
  • Lead the Medical Matrix Team and co-lead the cross-functional IBCT to tailor medical strategy for specific customer needs and the US environment.
  • Responsible for launch and product development including US data/content needs and indication expansion strategy.
  • Coordinate with US MSL and Field Policy and Payor teams to engage with key US stakeholders.
  • Measure and invest in medical activities to maximize impact on patient care.
  • Manage a team of medical directors supporting the Neisseria vaccines portfolio.
  • Accountable for the US budget for the Neisseria vaccines portfolio and for medical governance oversight/sign-off for asset indications.
  • Lead design and delivery of Phase IIIB/IV studies (US Pharma funded) and drive HEOR/RWE data-generation in collaboration with US HEOR and global teams.
  • Work with safety, regulatory, and manufacturing to ensure sound benefit-risk assessment and rapid integration of relevant changes.
  • Serve as the US medical affairs point of contact for safety issues related to Neisseria vaccines.
  • Provide input to study design and support local US/Canada study conduct activities for vaccine sponsor studies (Phase I–IV).

Qualifications

  • Required: Medical Doctor, PharmD, or PhD in life sciences with specialization in vaccinology, immunology, infectious diseases, microbiology, virology, life sciences, public health, pediatrics or health economics policy.
  • Required: 5+ years of industry and/or clinical experience in the relevant field through Medical Affairs or related functional areas (e.g., regulatory affairs, clinical development, public health, epidemiology, market access, discovery).
  • Required: Experience working effectively in large enterprise matrix teams; project management and leadership experience; proven ability to network and influence in a complex matrix environment.
  • Preferred: Thorough understanding of the US healthcare environment and external stakeholders; understanding of medical affairs accountabilities for strategic direction, evidence generation, external engagement, and internal advisory roles; direct experience preferred.
  • Preferred: Disease-area expertise with relevant medical/clinical experience; strong analytical skills to assess and interpret scientific data.
  • Preferred: Drug development experience across early development, launch, and lifecycle management; knowledge of GCP, regulatory, market access, reimbursement, and promotional codes/regulations.
  • Preferred: Demonstrated ability to engage, build, and sustain a broad external expert network; excellent written and verbal communication and presentation skills; experienced speaker on scientific/medical topics to diverse audiences.

Additional Requirements

  • Travel: up to 20% of working time.